Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 9 October 2024 31 October 2025 31 October 2025 16007020 Dr Saidalavi Kaithakkoden iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16007020 2024-10-08 16007020 2025-10-31 16007020 2024-10-09 2025-10-31 16007020 frs-core:CurrentFinancialInstruments 2025-10-31 16007020 frs-bus:PrivateLimitedCompanyLtd 2024-10-09 2025-10-31 16007020 frs-bus:FilletedAccounts 2024-10-09 2025-10-31 16007020 frs-bus:Micro-entities 2024-10-09 2025-10-31 16007020 frs-bus:AuditExempt-NoAccountantsReport 2024-10-09 2025-10-31 16007020 frs-bus:Director1 2024-10-09 2025-10-31
Registered number: 16007020
Therasphere Limited
Unaudited Financial Statements
For the Period 9 October 2024 to 31 October 2025
Balance Sheet
Registered number: 16007020
31 October 2025
£
Current assets 114,287
Creditors: Amounts Falling Due Within One Year (31,487 )
NET CURRENT ASSETS 82,800
TOTAL ASSETS LESS CURRENT LIABILITIES 82,800
Accruals and deferred income (299 )
NET ASSETS 82,501
CAPITAL AND RESERVES 82,501

Notes

1. General Information
Therasphere Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16007020 . The registered office is 72 Braemar Avenue, Bristol, BS7 0TQ.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Saidalavi Kaithakkoden
Director
11th June 2026